CDC Issues Guidelines Seeking To Cut Opioid Drug Use, Find Other Methods For Pain Relief
The draft recommendations from the federal Centers for Disease Control and Prevention suggest that doctors try different strategies. At the same time, a new study also looks at prescribers' role in the use of the opioid drugs, and Maryland relaxes its rules for getting a drug that can reverse the dangerous effects of opioids.
The Washington Post:
Hoping To Curb The Prescription Opioid Epidemic, CDC Proposes New Guidelines For Doctors
The government on Monday urged primary-care physicians who prescribe opioids for pain relief to rein in their use of the drugs, proposing new guidelines that call for a more conservative approach than the one that has led to a crippling epidemic of addiction to the powerful narcotics. Just a few days after a new report showed a surge of drug-related overdoses in 2014, the Centers for Disease Control and Prevention suggested in draft recommendations that physicians tackle chronic pain with other methods. (Bernstein, 12/14)
Kaiser Health News:
Broader Strategies Necessary To Counter Painkiller Over Prescribing, Researchers Say
There’s a prescription drug abuse problem sweeping the United States, but fixing it will require a systematic change focused on how most health professionals prescribe drugs, rather than changing the practices of a few bad apples. At least, that’s the recommendation put forth in a research letter published Monday in JAMA Internal Medicine. (Luthra, 12/15)
The Washington Post:
Maryland Pharmacists Can Sell Naloxone Without A Prescription
Maryland pharmacists will no longer require that people have a prescription to obtain a drug that can reverse the effects of opioid overdoses. The Maryland Department of Health and Mental Hygiene issued an order Monday authorizing pharmacists to dispense naloxone to thousands of individuals who have been trained and certified through the state’s Overdose Response Program. (Hicks, 12/14)
In other news, a study examines a possible factor in autism -
NPR:
A New Study Raises Old Questions About Antidepressants And Autism
Taking antidepressants during the second or third trimester of pregnancy may increase the risk of having a child with autism spectrum disorder, according to a study of Canadian mothers and children published Monday in JAMA Pediatrics. But scientists not involved in the research say the results are hard to interpret and don't settle the long-running debate about whether expectant mothers with depression should take antidepressants. (Hamilton, 12/14)
